M Peck-Radosavljevic1. 1. Department of Gastroenterology and Hepatology, Medizinische Universität & AKH Wien, Vienna, Austria. markus.peck@meduniwien.ac.at
Abstract
BACKGROUND: The liver is the site for synthesis of the vast majority of proteins that play a central role in maintaining hemostasis, by participating in the regulation of coagulation and fibrinolysis. AIM: To summarize the available data on the impact of coagulation disorders in patients with chronic liver disease. RESULTS: Hepatocellular damage in patients with severe liver disease can lead to abnormalities in the production and function of coagulation and fibrinolytic factors, disrupting the balance between coagulation and anticoagulation systems. CONCLUSIONS: Hemostatic abnormalities (eg. impaired synthesis of clotting factors, heightened fibrinolysis, disseminated intravascular coagulation, thrombocytopenia, and platelet dysfunction) can increase the risk of bleeding in cirrhotic patients.
BACKGROUND: The liver is the site for synthesis of the vast majority of proteins that play a central role in maintaining hemostasis, by participating in the regulation of coagulation and fibrinolysis. AIM: To summarize the available data on the impact of coagulation disorders in patients with chronic liver disease. RESULTS:Hepatocellular damage in patients with severe liver disease can lead to abnormalities in the production and function of coagulation and fibrinolytic factors, disrupting the balance between coagulation and anticoagulation systems. CONCLUSIONS:Hemostatic abnormalities (eg. impaired synthesis of clotting factors, heightened fibrinolysis, disseminated intravascular coagulation, thrombocytopenia, and platelet dysfunction) can increase the risk of bleeding in cirrhotic patients.
Authors: Agostino Colli; Juan Cristóbal Gana; Jason Yap; Thomasin Adams-Webber; Natalie Rashkovan; Simon C Ling; Giovanni Casazza Journal: Cochrane Database Syst Rev Date: 2017-04-26
Authors: V Takyar; O Etzion; T Heller; D E Kleiner; Y Rotman; M G Ghany; N Fryzek; V H Williams; E Rivera; S Auh; T J Liang; J H Hoofnagle; C Koh Journal: Aliment Pharmacol Ther Date: 2017-01-10 Impact factor: 8.171
Authors: John A Hermos; Arman Altincatal; H Christian Weber; Kelly Grotzinger; Kyle J Smoot; Kelly Cho; David R Gagnon; Elizabeth V Lawler Journal: Dig Dis Sci Date: 2012-09-26 Impact factor: 3.199
Authors: Dmitri Bezinover; Seyedehsan Navabi; Ming Wang; Zheng Li; Meryl William; Jonathan G Stine Journal: Transplant Proc Date: 2019 Jul - Aug Impact factor: 1.066
Authors: J X Moore; N A Zakai; M Mahalingam; R L Griffin; M R Irvin; M M Safford; J W Baddley; H E Wang Journal: J Thromb Haemost Date: 2016-09-23 Impact factor: 5.824